Literature DB >> 15044668

BMI is the main determinant of the circulating leptin in women after vertical banded gastroplasty.

Liolia Zabrocka1, Sylwia Raczynska, Elzbieta Goyke, Zbigniew Sledzinski, Julian Swierczynski.   

Abstract

OBJECTIVE: To assess the main determinant of serum leptin concentration changes in morbidly obese patients treated by banded vertical gastroplasty. RESEARCH METHODS AND PROCEDURES: Serum leptin and insulin concentrations, insulin resistance, BMI, body weight, and body fat mass in 18 obese women and 8 obese men treated by vertical banded gastroplasty were studied. Lean women and men subjects were used as controls.
RESULTS: Before surgery, serum leptin and insulin concentrations and insulin resistance index were significantly higher in morbidly obese patients than in control subjects. BMI, body fat mass, and serum triacylglycerol concentrations were also significantly higher in obese than in lean subjects. All of these parameters gradually decreased during 50 weeks after surgery. Univariate regression analysis displayed significant correlations between the following: serum leptin concentration and BMI (and body fat mass), serum leptin concentration and serum insulin concentration, and serum leptin concentration and insulin resistance index. Multivariate regression analysis indicated that only BMI was independently correlated with the decrease in serum leptin concentration. DISCUSSION: Obtained data suggest the following: 1) vertical banded gastroplasty causes reduction of body weight, serum leptin and insulin concentration, insulin resistance, and serum triacylglycerol concentration; and 2) BMI is the main determinant of the circulating leptin concentration in morbidly obese women after anti-obesity surgery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044668     DOI: 10.1038/oby.2004.57

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  8 in total

1.  Increased serum nitric oxide concentration after bariatric surgery--a potential mechanism for cardiovascular benefit.

Authors:  Tomasz Sledzinski; Maciej Sledzinski; Ryszard Tomasz Smolenski; Julian Swierczynski
Journal:  Obes Surg       Date:  2009-12-08       Impact factor: 4.129

2.  Bariatric surgery reverses natural killer (NK) cell activity and NK-related cytokine synthesis impairment induced by morbid obesity.

Authors:  Cristiane Martins Moulin; Ivo Marguti; Jean Pierre Schatzmann Peron; Alfredo Halpern; Luiz Vicente Rizzo
Journal:  Obes Surg       Date:  2011-01       Impact factor: 4.129

3.  Serum phenylalanine concentration as a marker of liver function in obese patients before and after bariatric surgery.

Authors:  Julian Swierczynski; Tomasz Sledzinski; Ewa Slominska; Ryszard Smolenski; Zbigniew Sledzinski
Journal:  Obes Surg       Date:  2008-04-23       Impact factor: 4.129

4.  Decrease in serum protein carbonyl groups concentration and maintained hyperhomocysteinemia in patients undergoing bariatric surgery.

Authors:  T Sledzinski; E Goyke; R T Smolenski; Z Sledzinski; J Swierczynski
Journal:  Obes Surg       Date:  2008-10-02       Impact factor: 4.129

5.  Obesity, Inflammation and Acute Myocardial Infarction - Expression of leptin, IL-6 and high sensitivity-CRP in Chennai based population.

Authors:  Karthick Rajendran; Nalini Devarajan; Manohar Ganesan; Malathi Ragunathan
Journal:  Thromb J       Date:  2012-08-14

6.  Pharmacological effects of JTT-551, a novel protein tyrosine phosphatase 1B inhibitor, in diet-induced obesity mice.

Authors:  Makoto Ito; Sumiaki Fukuda; Shohei Sakata; Hisayo Morinaga; Takeshi Ohta
Journal:  J Diabetes Res       Date:  2014-05-29       Impact factor: 4.011

Review 7.  Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome.

Authors:  Lukasz Kaska; Tomasz Sledzinski; Agnieszka Chomiczewska; Agnieszka Dettlaff-Pokora; Julian Swierczynski
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

Review 8.  The Causes and Potential Injurious Effects of Elevated Serum Leptin Levels in Chronic Kidney Disease Patients.

Authors:  Justyna Korczynska; Aleksandra Czumaj; Michal Chmielewski; Julian Swierczynski; Tomasz Sledzinski
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.